What is the average price target for OMNICELL INC (OMCL) stock?
14 analysts have analysed OMCL and the average price target is 58.58 USD. This implies a price increase of 71.53% is expected in the next year compared to the current price of 34.15.
NASDAQ:OMCL • US68213N1090
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OMNICELL INC (OMCL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-06 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2026-02-02 | Benchmark | Maintains | Buy -> Buy |
| 2026-01-08 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2026-01-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-09 | Benchmark | Maintains | Buy -> Buy |
| 2025-10-31 | Benchmark | Maintains | Buy -> Buy |
| 2025-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-23 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-05-14 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-05-07 | Benchmark | Maintains | Buy -> Buy |
| 2025-05-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-17 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-02-04 | Benchmark | Maintains | Buy -> Buy |
| 2025-01-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-06 | B of A Securities | Maintains | Neutral -> Neutral |
| 2024-11-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-10-31 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-31 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-10-31 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-10-14 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-09 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.147B -11.48% | 1.112B -3.04% | 1.185B 6.53% | 1.265B 6.77% | 1.331B 5.22% | 1.392B 4.58% | 1.356B -2.59% | 1.494B 10.18% | 1.566B 4.82% | 1.608B 2.68% | 1.65B 2.61% | |
| EBITDA YoY % growth | 67.99M -36.69% | 87.722M 29.02% | 90.46M 3.12% | 154.39M 70.67% | 179.13M 16.02% | 209.41M 16.90% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -19.329M -194.29% | 5.49M 128.40% | 11.665M 112.48% | 92.461M 692.64% | 113.81M 23.09% | 125.25M 10.05% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -1.69% | 0.49% | 0.98% | 7.31% | 8.55% | 9.00% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 1.91 -36.33% | 1.70 -10.99% | 1.62 -4.71% | 1.79 10.28% | 2.13 19.25% | 2.58 21.14% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 26.03% | 0.42 -6.22% | 0.49 -4.00% | 0.54 35.79% | 0.37 13.10% | 0.53 26.48% | 0.56 15.28% | 0.63 16.43% | 0.39 4.59% | 0.67 26.12% | 0.73 30.12% | 0.79 24.19% |
| Revenue Q2Q % growth | 310.07M 14.98% | 310.92M 7.01% | 318.42M 2.51% | 325.27M 3.59% | 323.44M 4.31% | 324.49M 4.36% | 334.19M 4.95% | 340.19M 4.59% | 352.61M 9.02% | 344.35M 6.12% | 369.75M 10.64% | 375.67M 10.43% |
| EBITDA Q2Q % growth | 31.527M 276.40% | 37.132M -22.16% | 41.079M -38.90% | 44.301M -44.07% | 35.311M 12.00% | 42.807M 15.28% | 46.234M 12.55% | 50.042M 12.96% | 37.128M 5.15% | 53.55M 25.10% | 57.732M 24.87% | 60.996M 21.89% |
| EBIT Q2Q % growth | 16.576M 242.66% | 21.295M 162.25% | 25.83M 213.32% | 28.666M 6,807.47% | 19.331M 16.62% | 28.297M 32.88% | 30.112M 16.58% | 33.91M 18.29% | 21.726M 12.39% | 37.74M 33.37% | 41.718M 38.54% | 44.676M 31.75% |
All data in USD
14 analysts have analysed OMCL and the average price target is 58.58 USD. This implies a price increase of 71.53% is expected in the next year compared to the current price of 34.15.
OMNICELL INC (OMCL) will report earnings on 2026-05-04, before the market open.
The consensus EPS estimate for the next earnings of OMNICELL INC (OMCL) is 0.33 USD and the consensus revenue estimate is 310.07M USD.
The expected long term growth rate for OMNICELL INC (OMCL) is 4.84%.